A putative class action targeting Rodan + Fields, LLC in California federal court could draw fresh attention to the use of prostaglandin analogs in cosmetic eyelash enhancers, an issue that has sparked FDA enforcement action in the past, as well as unfair competition suits from Latisse owner Allergan plc.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?